The FDA withdrew its proposed mandatory asbestos testing rule for talc-containing cosmetics in late 2025 [15], leaving American consumers without federal testing protections even as FDA sampling detected asbestos fibers in 9 of 52 cosmetic talc products tested in 2019 [1]. A peer-reviewed case series found that the majority of mesothelioma patients with cosmetic talc exposure had no other identified asbestos source, suggesting talc is a significant pathway for mesothelioma in women [3] — a regulatory crisis that diverges sharply from the European Union's move to ban talc in cosmetics after classifying it as a Category 1B carcinogen [4].
Executive Summary
The FDA's withdrawal of its proposed talc testing rule eliminates the only pending federal requirement for cosmetics manufacturers to screen the mineral's products for asbestos contamination [2]. This decision comes despite the agency's own 2019 testing program detecting asbestos in 9 of 52 sampled cosmetic powder products [1]. For women—who represent a growing share of pleural mesothelioma diagnoses—the implications are significant: a peer-reviewed case series of 166 mesothelioma patients with cosmetic talc exposure found that in 122 cases, the substance was the only identified asbestos source [3]. The EU has moved in the opposite direction, with ECHA's risk assessment committee classifying talc as a Category 1B carcinogen in September 2024 — a decision expected to lead to a full cosmetics ban once formally adopted [4]. Court documents from ongoing litigation have revealed that major manufacturers knew about asbestos contamination in their supplies for decades. For individuals diagnosed with mesothelioma after long-term use of the powder, this regulatory gap underscores the importance of understanding both compensation options and the evolving legal landscape surrounding talc liability.
Key Facts
- The FDA withdrew its proposed mandatory talc-asbestos testing rule in late 2025, removing the only pending federal testing requirement for cosmetic talc products
- FDA testing in 2019 detected asbestos in 9 of 52 cosmetic powder products sampled from retail shelves, prompting consumer safety alerts and product recalls
- In a peer-reviewed case series of 166 mesothelioma patients with cosmetic talc exposure, 122 had no other identified asbestos source — suggesting the mineral is the primary pathway for many non-occupational cases
- ECHA's risk assessment committee classified talc as a Category 1B carcinogen in September 2024, a decision expected to trigger a cosmetics ban across EU member states once formally adopted
- Talc and asbestos form in the same geological deposits, making contamination of the mined mineral a persistent geological reality
- Johnson & Johnson discontinued talc-based baby powder globally in 2023 after court documents revealed decades of known contamination; its third bankruptcy bid to resolve claims was rejected in March 2025
- The Modernization of Cosmetics Regulation Act (MoCRA) of 2022 gave the FDA expanded authority, but the withdrawn rule leaves that authority unexercised for talc
- Cosmetic products potentially containing the contaminated ingredient include baby powder, facial powder, foundation, blush, eye shadow, body powder, and dry shampoo
- Women's mesothelioma incidence has not declined as sharply as men's, with non-occupational exposure sources including cosmetic powder suspected as a contributing factor
- Mesothelioma patients with talc exposure history may pursue product liability lawsuits and asbestos trust fund claims against manufacturers
What Did the FDA's Proposed Talc Testing Rule Require?
The FDA's proposed rule, developed under the authority granted by the Modernization of Cosmetics Regulation Act (MoCRA) of 2022, would have established the first mandatory federal requirement for cosmetics manufacturers to test the mineral in ingredients and finished products for asbestos contamination [5]. The proposed framework included standardized analytical testing methods, batch-level documentation requirements, and reporting obligations when asbestos was detected above specified thresholds.
Prior to the proposal, no federal regulation required cosmetics companies to test the ingredient for asbestos contamination before selling products to consumers. The industry relied on voluntary self-regulation through trade organizations, with companies conducting their own testing using varying methods and standards. The FDA's 2019 sampling program — which detected asbestos in 9 of 52 tested products, triggering recalls of contaminated cosmetics from brands including Claire's — demonstrated the inadequacy of this voluntary approach [1].
"The FDA's own testing proved that voluntary compliance was failing consumers. When nearly one in five tested products on retail shelves contain a known carcinogen, the regulatory system has a fundamental credibility problem."
— Rod De Llano, Founding Partner, Danziger & De Llano
The rule withdrawal occurred despite bipartisan congressional support for stronger cosmetics oversight and growing scientific evidence connecting the mineral to cancer. Industry groups had submitted extensive comments opposing the proposed testing requirements, citing cost burdens, analytical methodology disputes, and concerns about detection thresholds [6].
Why Does Talc Contain Asbestos Contamination?
The connection between talc and asbestos is geological, not manufacturing-related. Both minerals are hydrous magnesium silicates that form under similar geological conditions, and deposits of the mineral frequently occur adjacent to or interspersed with asbestos-bearing rock formations [7]. When talc is mined, asbestos fibers—particularly tremolite, anthophyllite, and chrysotile—can be incorporated into the extracted material.
The types of asbestos fibers found in contaminated talc are among the most dangerous. Tremolite and anthophyllite are amphibole asbestos varieties that are more biopersistent than chrysotile, meaning they remain in lung tissue longer and cause more sustained cellular damage [8]. Research has confirmed that conventional milling and processing of the substance does not reliably remove asbestos fibers, and some processing steps may actually reduce fiber size, increasing their ability to penetrate deep into the lungs [8].
The International Agency for Research on Cancer (IARC) classifies the asbestos-contaminated substance as a Group 1 carcinogen—the highest classification, indicating sufficient evidence of carcinogenicity in humans [9]. This classification encompasses not only mesothelioma risk but also ovarian cancer and lung cancer associated with exposure to the powder.
How Are Women Disproportionately Affected by Talc-Related Mesothelioma?
While men account for approximately 80% of mesothelioma diagnoses due to occupational asbestos exposure, women face a distinct and underrecognized exposure pathway through talc-containing consumer products [11]. A peer-reviewed case series published in the Journal of Occupational Medicine and Toxicology examined 166 mesothelioma patients with documented cosmetic talc exposure and found that in 122 cases (73.5%), the product was the only identified asbestos source — cases that would otherwise have been classified as idiopathic [3].
The exposure pattern for women differs fundamentally from occupational exposure. Where industrial workers experienced intense, concentrated asbestos exposure over shifts and years, women using the products were exposed to lower concentrations of asbestos fibers daily over decades—sometimes beginning in infancy with baby powder application and continuing through adult use of body powders, facial cosmetics, and hygiene products [12].
"When we evaluate female mesothelioma cases with no workplace asbestos exposure, the most common thread is decades of daily talc product use. The cumulative exposure from what seemed like a harmless hygiene routine can be devastating."
— Rod De Llano, Founding Partner, Danziger & De Llano
Epidemiological data shows that female mesothelioma mortality rates have not declined as steeply as male rates in recent decades [13]. While the male decline reflects reduced occupational exposure after regulatory changes in the 1970s and 1980s, the persistence of female mesothelioma rates suggests ongoing non-occupational exposure sources. Hairdressers and barbers face additional occupational exposure to the substance through professional use of powder-containing styling products, creating a dual-exposure pathway for women in these professions.
Women also experience secondary asbestos exposure by laundering work clothing contaminated with asbestos fibers brought home by spouses and family members employed in asbestos-intensive industries. The combination of secondary household exposure and personal cosmetic powder use may create compounding cancer risk that neither source alone would produce.
How Does the EU Talc Ban Compare to U.S. Regulation?
The divergence between European and American regulatory approaches to talc has created a two-tier safety standard for consumers on either side of the Atlantic. In September 2024, ECHA's Committee for Risk Assessment (RAC) concluded that talc should be classified as a Category 1B carcinogen under the Classification, Labelling and Packaging (CLP) Regulation [4]. Once the European Commission formally adopts this classification, it would trigger a mandatory phase-out of the substance in all cosmetic products across EU member states, with industry sources expecting a ban as early as 2027.
The EU's classification is based on the principle that asbestos contamination of the mineral is an inherent geological risk that cannot be eliminated through processing or testing, making the mineral itself presumptively dangerous when used in products applied to the human body. This precautionary approach contrasts with the U.S. regulatory philosophy, which has historically required proof of harm in finished products rather than addressing inherent contamination risk [6].
Following the FDA's rule withdrawal, the United States now has: no federal ban on the ingredient in cosmetics, no mandatory testing requirement for asbestos contamination, no standardized analytical methods required for voluntary testing, and no reporting obligation when contamination is discovered. Individual states have begun pursuing their own regulations, but the patchwork approach leaves most American consumers without consistent protections.
| Regulatory Measure | European Union | United States |
|---|---|---|
| Talc classification | Category 1B carcinogen (ECHA, 2024) | No federal carcinogen classification for the mineral |
| Cosmetics ban | Expected ban (pending Commission adoption) | No ban planned |
| Mandatory testing | Covered under cosmetics safety framework | No requirement (proposed rule withdrawn) |
| Contamination reporting | Required under REACH regulation | No federal reporting obligation |
| Consumer labeling | Carcinogen warning required | No warning required |
What Did Court Documents Reveal About Industry Knowledge of Contamination?
Litigation against talc manufacturers has produced a trove of internal corporate documents demonstrating that companies were aware of asbestos contamination in their supplies of the mineral for decades before public disclosure. Johnson & Johnson—the largest defendant in talc litigation—faced particularly damaging revelations when internal memos, geological surveys, and laboratory reports were unsealed during trial proceedings [16].
Documents dating to the 1970s showed that company geologists and laboratory scientists detected asbestos fibers—including tremolite, anthophyllite, and chrysotile—in raw material sourced from mines in Vermont, Italy, and China. Internal correspondence discussed strategies for responding to regulatory inquiries about contamination, and some documents referenced concerns about liability exposure if contamination became publicly known [16].
"The corporate documentation trail in this litigation is extraordinary. Companies had their own scientists confirming asbestos contamination while simultaneously assuring consumers and regulators that their products were safe. This level of concealment defines corporate liability."
— Rod De Llano, Founding Partner, Danziger & De Llano
Johnson & Johnson discontinued its talc-based baby powder in North America in 2020 and worldwide in 2023, replacing the formula with cornstarch. The company has faced tens of thousands of lawsuits related to the contamination and attempted multiple corporate restructuring strategies — including controversial subsidiary bankruptcy filings — to manage its product litigation liability. Courts have repeatedly rejected these restructuring attempts, including a March 2025 ruling striking down J&J's proposed $8 billion settlement [16]. The full scope of talc litigation is detailed in our guide to the 90,000 talc lawsuits that make up the largest mass tort in U.S. history, including J&J's failed bankruptcy strategies and the IARC reclassification.
What Cosmetic Products May Contain Asbestos-Contaminated Talc?
Talc's properties—its ability to absorb moisture, prevent caking, and create a smooth texture—make it a widely used ingredient in cosmetics and personal care products that extends far beyond baby powder. The FDA's testing program detected asbestos in products across multiple cosmetic categories sold at major retailers and discount stores [1].
Products that commonly contain the ingredient include facial pressed powder and loose powder, foundation and tinted moisturizer, blush and bronzer, eye shadow, body and bath powder, dry shampoo, deodorant and antiperspirant, and certain pharmaceutical tablets using the substance as a coating agent. The absence of mandatory testing means consumers cannot verify through labeling whether any specific product has been screened for asbestos [5].
Application method significantly affects exposure risk. Products applied as loose powders create airborne dust clouds that facilitate inhalation of any asbestos fibers present. Pressed powders and liquid formulations may reduce but do not eliminate inhalation risk. Genital application of the powder—historically marketed for feminine hygiene—creates both inhalation and peritoneal exposure pathways [8].
What Legal Options Exist for Mesothelioma Patients With Talc Exposure?
Individuals diagnosed with mesothelioma who have a history of cosmetic powder use may have several legal avenues for pursuing compensation, even in the absence of documented occupational asbestos exposure. The legal framework for mesothelioma claims linked to the product has expanded significantly through precedent-setting verdicts and settlements [16].
Product liability claims target manufacturers, distributors, and retailers of products containing the substance that were contaminated with asbestos. These claims typically allege that companies knew or should have known about contamination risks, failed to adequately test their products, and failed to warn consumers. Juries have awarded significant verdicts in these mesothelioma cases — the $2.5 billion in talc mesothelioma jury verdicts recorded in 2025 alone reflects the scale of accountability courts have imposed on manufacturers — with individual awards reaching into the hundreds of millions of dollars.
Asbestos trust fund claims may be available when the companies that mined or supplied the contaminated mineral have established bankruptcy trusts. Multiple asbestos trust funds cover exposure to the product, and patients may be eligible to file claims with several trusts simultaneously. An experienced mesothelioma attorney can identify which trusts apply to a specific patient's exposure history and product use.
Statute of limitations for mesothelioma claims typically begins at the date of diagnosis rather than the date of exposure—a critical distinction given the disease's 20-50 year latency period. This "discovery rule" gives newly diagnosed patients a window to pursue legal action regardless of how long ago their exposure to the substance occurred. However, filing deadlines vary by state and claim type, making early legal consultation essential.
"Many patients and families don't realize that decades of using cosmetic powder products can form the basis of a viable mesothelioma claim. The FDA's failure to require testing doesn't diminish manufacturers' liability—it strengthens the argument that the industry prioritized profits over consumer safety."
— Rod De Llano, Founding Partner, Danziger & De Llano
What Should Consumers and Patients Know Going Forward?
The FDA's rule withdrawal shifts the burden of safety verification from manufacturers to consumers—a reversal of the regulatory intent behind MoCRA. For consumers currently using talc products, there is no reliable way to determine whether a specific product contains asbestos contamination without independent laboratory testing [2]. Safer alternatives include cornstarch-based powders, arrowroot powder, and talc-free cosmetic formulations, which are increasingly available from major brands.
For individuals already diagnosed with mesothelioma who have a history of talc use, documenting the specific products used, the duration and frequency of use, and the manner of application (inhalation, genital, general body) is critical for both medical evaluation and potential legal claims. Medical providers should be informed about talc exposure history, as it may influence treatment planning and clinical trial eligibility [3].
The gap between EU and U.S. regulation is expected to narrow as state-level initiatives, ongoing litigation pressure, and evolving scientific evidence build momentum for federal action. In the interim, the legal system remains the primary accountability mechanism for consumers harmed by asbestos-contaminated talc products. A free case evaluation can help mesothelioma patients and families determine whether talc exposure contributed to their diagnosis and what compensation options may be available.
Frequently Asked Questions
Why did the FDA withdraw its proposed talc testing rule?
The FDA withdrew its proposed rule requiring mandatory asbestos testing of talc-containing cosmetics in late 2025, citing resource constraints, shifting regulatory priorities, and industry opposition during the comment period. The proposed rule, first introduced under MoCRA of 2022, would have required manufacturers to test talc products for asbestos using standardized methods [5]. Consumer safety advocates criticized the withdrawal, arguing it leaves a gap allowing potentially contaminated products on shelves without mandatory screening.
How much of women's mesothelioma may be linked to talc exposure?
A case series of 166 mesothelioma patients with documented cosmetic talc exposure found that in 122 cases, talc was the only identified asbestos source [3]. Unlike men — whose mesothelioma is linked to workplace exposure — women's exposure pathways frequently involve decades of daily talc use. FDA testing in 2019 detected asbestos in 9 of 52 cosmetic talc products sampled from retail shelves [1].
What is the connection between talc and asbestos?
Talc and asbestos are naturally occurring minerals that frequently form in the same geological deposits. Mined talc is often contaminated with asbestos fibers—particularly tremolite, anthophyllite, and chrysotile [7]. When applied as cosmetics, microscopic asbestos fibers can be inhaled or absorbed. IARC classifies asbestos-contaminated talc as carcinogenic to humans, and ECHA classified talc itself as a Category 1B carcinogen in 2024.
How does the EU talc ban differ from U.S. regulation?
ECHA's risk assessment committee classified talc as a Category 1B carcinogen in September 2024, a step expected to lead to a full EU cosmetics ban once the European Commission formally adopts the classification [4]. The U.S. has no federal ban, no mandatory testing requirement after the FDA withdrawal, and relies on voluntary industry self-regulation. This creates a two-tier safety standard where European consumers are positioned for stronger protections while Americans continue using products that may contain asbestos-contaminated talc.
What legal options do mesothelioma patients with talc exposure have?
Patients may pursue product liability lawsuits against manufacturers who knew about contamination, file asbestos trust fund claims, and in some cases pursue claims against retailers. The statute of limitations typically begins at diagnosis, not exposure, giving newly diagnosed patients time to act. An experienced mesothelioma attorney can evaluate whether talc exposure contributed to the diagnosis.
Did Johnson & Johnson know about asbestos in its talc products?
Court documents revealed J&J had internal knowledge of asbestos contamination dating to the 1970s. Internal memos, geological surveys, and testing records showed the company detected asbestos in talc across multiple decades without disclosing findings to regulators or consumers [16]. J&J discontinued talc-based baby powder globally in 2023 and has faced tens of thousands of lawsuits, with courts rejecting multiple bankruptcy restructuring attempts [16].
What cosmetic products may contain asbestos-contaminated talc?
Products potentially containing contaminated talc include baby powder, facial powder, foundation, blush, eye shadow, body powder, dry shampoo, deodorant, and pharmaceutical tablets with talc coatings [1]. Loose powders create the highest inhalation risk. The lack of mandatory testing means consumers cannot verify whether a specific product is free of asbestos contamination.
References
- Testing of Cosmetic Talc Products for Asbestos Contamination. U.S. Food and Drug Administration. 2025. https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/talc
- FDA Authority Over Cosmetics: Talc and Asbestos Testing. U.S. Food and Drug Administration. 2025. https://www.fda.gov/cosmetics
- Exposure to cosmetic talc and mesothelioma. Journal of Occupational Medicine and Toxicology. 2023. https://pubmed.ncbi.nlm.nih.gov/36653798/
- Highlights from September 2024 RAC and SEAC meetings. European Chemicals Agency. 2024. https://www.echa.europa.eu/-/highlights-from-september-2024-rac-and-seac-meetings
- FDA Regulation of Cosmetics and Personal Care Products Under MoCRA. Congressional Research Service. 2023. https://www.congress.gov/crs-product/R47826
- Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products — Proposed Rule. Federal Register. 2024. https://www.federalregister.gov/documents/2024/12/27/2024-30544/
- Asbestos Toxicological Profile. Agency for Toxic Substances and Disease Registry. 2024. https://www.atsdr.cdc.gov/ToxProfiles/tp61.pdf
- Asbestos in commercial cosmetic talcum powder as a cause of mesothelioma in women. International Journal of Occupational and Environmental Health. 2014. https://pubmed.ncbi.nlm.nih.gov/25185462/
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans — Asbestos (Chrysotile, Amosite, Crocidolite, Tremolite, Actinolite, and Anthophyllite). Vol. 100C. International Agency for Research on Cancer. 2012. IARC Monographs Vol. 100C
- Asbestos Fiber Types and Potency. WikiMesothelioma. https://wikimesothelioma.com/Asbestos_Fiber_Types_and_Potency
- Malignant Mesothelioma Mortality in Women — United States, 1999-2020. MMWR Morbidity and Mortality Weekly Report. 2022. https://pubmed.ncbi.nlm.nih.gov/35552365/
- Asbestos: Health Effects. Centers for Disease Control and Prevention / ATSDR. 2024. https://www.atsdr.cdc.gov/toxprofiles/tp61.html
- Incidence of Malignant Mesothelioma. U.S. Cancer Statistics, Centers for Disease Control and Prevention. 2024. https://www.cdc.gov/united-states-cancer-statistics/publications/mesothelioma.html
- Hairdressers and Barbers. WikiMesothelioma. https://wikimesothelioma.com/Hairdressers_and_Barbers
- [15] Federal Register — Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products; Withdrawal. November 28, 2025.
- [16] Marketplace / APM — Johnson & Johnson tried 3 times to resolve talc suits in bankruptcy court. It didn't work. April 2025.
Related Articles
About the Author
Rod De LlanoFounding Partner at Danziger & De Llano, Princeton graduate with corporate defense background
Related Topics
Related Articles
J&J's Texas Two-Step Bankruptcy Defeated: What 3 Failed Attempts Mean for Talc Victims
J&J's three Texas Two-Step bankruptcy attempts all failed in court. May 2026 trial-court status: MDL 2738 active, 62-67k pending plaintiffs.
Imerys Talc $1B+ Trust: When Will Victims See Settlement Payments?
Imerys + Cyprus Mines $1B+ talc trust: plan voting passed Jan 2025, insurer challenges continued Feb 2026, payouts could begin 2026.
Who Is Liable for Your Asbestos Exposure? 3 Defendants Compared in 2026
Employers, manufacturers, and property owners can all be liable for asbestos exposure. Learn how each defendant type is held accountable and how to maximize compensation.
Need Help With Your Case?
If you or a loved one has been diagnosed with mesothelioma, our experienced attorneys can help you understand your options and pursue the compensation you deserve.